Dimitri Brinet

Novel Trimodal MALDI Imaging Mass Spectrometry (IMS3) at 10 μm Reveals Spatial Lipid and Peptide Correlates Implicated in Aβ Plaque Pathology in Alzheimer’s Disease

Ibrahim Kaya, Dimitri Brinet, Wojciech Michno et al. · ACS Chemical Neuroscience · 2017 · 109 citations · Full text

Engineering, Biological Mass Spectrometry, Neurochemical Biomarkers +28

Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer’s Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry

Ibrahim Kaya, Dimitri Brinet, Wojciech Michno et al. · ACS Chemical Neuroscience · 2016 · 100 citations · Full text

Biological Mass Spectrometry, Neurochemical Biomarkers, Peptide Science +23

Histology-Compatible MALDI Mass Spectrometry Based Imaging of Neuronal Lipids for Subsequent Immunofluorescent Staining

Ibrahim Kaya, Wojciech Michno, Dimitri Brinet et al. · Analytical Chemistry · 2017 · 79 citations

Immunocytochemical Technique, Engineering, Biological Mass Spectrometry +21

Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1–40 deposition underlies plaque polymorphism in progressing Alzheimer’s disease pathology

Wojciech Michno, Sofie Nyström, Patrick M. Wehrli et al. · Journal of Biological Chemistry · 2019 · 69 citations · Full text

Neurodegenerative Diseases, Aβ1–40 Deposition Underlies, Alzheimer's Disease +11

Designed Glycopeptidomimetics Disrupt Protein–Protein Interactions Mediating Amyloid β-Peptide Aggregation and Restore Neuroblastoma Cell Viability

Julia Kaffy, Dimitri Brinet, Jean‐Louis Soulier et al. · Journal of Medicinal Chemistry · 2016 · 40 citations · Full text

Peptide Engineering, Glycobiology, Neurochemical Biomarkers +19